Investigating the role of in intrinsic resistance to multiple drugs in .

Buhari Yusuf, Shuai Wang, Md Shah Alam, Jingran Zhang, Zhiyong Liu, Ziwen Lu, Jie Ding, Gift Chiwala, Yamin Gao, Cuiting Fang, Shahzad Akbar Khan, Xirong Tian, Md Mahmudul Islam, H M Adnan Hameed, Dmitry A Maslov, Nanshan Zhong, Jinxing Hu, Tianyu Zhang
Author Information
  1. Buhari Yusuf: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. ORCID
  2. Shuai Wang: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. ORCID
  3. Md Shah Alam: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  4. Jingran Zhang: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  5. Zhiyong Liu: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  6. Ziwen Lu: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  7. Jie Ding: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  8. Gift Chiwala: Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi.
  9. Yamin Gao: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  10. Cuiting Fang: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  11. Shahzad Akbar Khan: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  12. Xirong Tian: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  13. Md Mahmudul Islam: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  14. H M Adnan Hameed: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  15. Dmitry A Maslov: Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  16. Nanshan Zhong: Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Diseases, Guangzhou, China.
  17. Jinxing Hu: Guangzhou National Laboratory, Guangzhou, China.
  18. Tianyu Zhang: State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. ORCID

Abstract

The increasing clinical significance of is owed to its innate high-level, broad-spectrum resistance to antibiotics and therefore rapidly evolves as an important human pathogen. This warrants the identification of novel targets for aiding the discovery of new drugs or drug combinations to treat infections. This study is inspired by the drug-hypersensitive profile of a mutant (U14) with transposon insertion in . We validated the role of in intrinsic drug resistance in by constructing a selectable marker-free in-frame deletion in and complementing the mutant with the same or extended version of the gene and then followed by drug susceptibility testing. Judging by the putative function of MAB_1915, cell envelope permeability was studied by ethidium bromide accumulation assay and susceptibility testing against dyes and detergents. In this study, we established genetic evidence of the role of in intrinsic resistance to rifampicin, rifabutin, linezolid, clarithromycin, vancomycin, and bedaquiline. Disruption of has also been observed to cause a significant increase in cell envelope permeability in . Restoration of resistance is observed to depend on at least 27 base pairs upstream of the coding DNA sequence of . MAB_1915 could therefore be associated with cell envelope permeability, and hence its role in intrinsic resistance to multiple drugs in , which presents it as a novel target for future development of effective antimicrobials to overcome intrinsic drug resistance in .
IMPORTANCE: This study reports the role of a putative fadD (MAB_1915) in innate resistance to multiple drugs by , hence identifying MAB_1915 as a valuable target and providing a baseline for further mechanistic studies and development of effective antimicrobials to check the high level of intrinsic resistance in this pathogen.

Keywords

References

  1. Chem Biol. 2009 May 29;16(5):510-9 [PMID: 19477415]
  2. J Biol Chem. 2005 Mar 11;280(10):8862-74 [PMID: 15632194]
  3. mSystems. 2020 Oct 20;5(5): [PMID: 33082279]
  4. Genome Biol. 2007;8(2):R20 [PMID: 17295914]
  5. Mol Cell. 2000 Apr;5(4):717-27 [PMID: 10882107]
  6. Microbiology (Reading). 2002 Oct;148(Pt 10):2975-2986 [PMID: 12368431]
  7. Mol Microbiol. 2002 Sep;45(6):1515-26 [PMID: 12354222]
  8. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D338-43 [PMID: 16381882]
  9. Appl Environ Microbiol. 2010 Aug;76(15):5312-6 [PMID: 20543044]
  10. BMC Microbiol. 2011 Feb 18;11:35 [PMID: 21332993]
  11. Microbiol Spectr. 2022 Aug 31;10(4):e0276321 [PMID: 35946941]
  12. G3 (Bethesda). 2020 Jan 7;10(1):13-22 [PMID: 31719113]
  13. J Bacteriol. 2005 Nov;187(22):7596-606 [PMID: 16267284]
  14. Chem Biol. 2014 Oct 23;21(10):1293-1299 [PMID: 25308274]
  15. J Antimicrob Chemother. 2008 May;61(5):1076-82 [PMID: 18310137]
  16. Antimicrob Agents Chemother. 2017 Jan 24;61(2): [PMID: 27855077]
  17. Microbiol Spectr. 2022 Aug 31;10(4):e0128822 [PMID: 35862962]
  18. PLoS One. 2015 Jun 25;10(6):e0131694 [PMID: 26110649]
  19. Springerplus. 2015 Nov 04;4:672 [PMID: 26558175]
  20. Mol Microbiol. 2008 Jul;69(1):164-74 [PMID: 18466296]
  21. Bioorg Med Chem. 2012 Apr 15;20(8):2701-6 [PMID: 22459211]
  22. Biomed Res Int. 2015;2015:506598 [PMID: 26146620]
  23. BMC Evol Biol. 2008 Mar 06;8:78 [PMID: 18325090]
  24. J Infect Dis. 2010 Apr 15;201(8):1232-9 [PMID: 20214478]
  25. J Biol Chem. 2001 Jun 8;276(23):19845-54 [PMID: 11279114]
  26. Antibiotics (Basel). 2020 Jul 08;9(7): [PMID: 32650510]
  27. Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10147-E10156 [PMID: 30301802]
  28. Antimicrob Agents Chemother. 2017 Oct 24;61(11): [PMID: 28874378]
  29. J Bacteriol. 2002 Dec;184(24):6796-802 [PMID: 12446629]
  30. Nature. 1998 Jun 11;393(6685):537-44 [PMID: 9634230]
  31. Infect Immun. 2012 Apr;80(4):1381-9 [PMID: 22290144]
  32. Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E1002-E1011 [PMID: 29343644]
  33. Biomed Res Int. 2018 Dec 30;2018:4902941 [PMID: 30687747]
  34. Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4958-63 [PMID: 24639491]
  35. Mol Microbiol. 2000 May;36(3):630-7 [PMID: 10844652]
  36. Nat Rev Microbiol. 2020 Jul;18(7):392-407 [PMID: 32086501]
  37. Antimicrob Agents Chemother. 2009 Sep;53(9):3799-802 [PMID: 19596883]
  38. Microbiology (Reading). 2007 Sep;153(Pt 9):3133-3140 [PMID: 17768256]
  39. Curr Opin Microbiol. 2004 Apr;7(2):102-8 [PMID: 15063844]
  40. Nat Methods. 2007 Feb;4(2):147-52 [PMID: 17179933]
  41. Microbiology (Reading). 2007 Feb;153(Pt 2):521-528 [PMID: 17259624]
  42. Open Biol. 2017 Feb;7(2): [PMID: 28228470]
  43. FEBS J. 2010 Jun;277(12):2715-25 [PMID: 20553505]
  44. Appl Environ Microbiol. 2020 Dec 11;87(5): [PMID: 33310719]

Grants

  1. 2021YFA1300900/National Key R&D Program of China
  2. 81973372,21920102003/MOST | National Natural Science Foundation of China (NSFC)
  3. 154144KYSB20190005,YJKYYQ20210026/Chinese Academy of Sciences Grants
  4. 2023YFSY0047/Key R&D Program of Sichuan Province
  5. SKLRD-OP-202324,SKLRD-Z-202301,SKLRD-OP-202113,SKLRD-Z-202412/State Key Laboratory of Respiratory Disease (SKLRD)

MeSH Term

Mycobacterium abscessus
Anti-Bacterial Agents
Microbial Sensitivity Tests
Mycobacterium Infections, Nontuberculous
Humans
Drug Resistance, Multiple, Bacterial
Clarithromycin
Bacterial Proteins
Vancomycin
Linezolid
Diarylquinolines
Rifampin
DNA Transposable Elements

Chemicals

Anti-Bacterial Agents
Clarithromycin
Bacterial Proteins
Vancomycin
bedaquiline
Linezolid
Diarylquinolines
Rifampin
DNA Transposable Elements

Word Cloud

Created with Highcharts 10.0.0resistanceintrinsicdrugroleMAB_1915drugscellenvelopepermeabilitystudymultipleinnatethereforepathogennovelmutantsusceptibilitytestingputativeobservedhencetargetdevelopmenteffectiveantimicrobialsincreasingclinicalsignificanceowedhigh-levelbroad-spectrumantibioticsrapidlyevolvesimportanthumanwarrantsidentificationtargetsaidingdiscoverynewcombinationstreatinfectionsinspireddrug-hypersensitiveprofileU14transposoninsertionvalidatedconstructingselectablemarker-freein-framedeletioncomplementingextendedversiongenefollowedJudgingfunctionstudiedethidiumbromideaccumulationassaydyesdetergentsestablishedgeneticevidencerifampicinrifabutinlinezolidclarithromycinvancomycinbedaquilineDisruptionalsocausesignificantincreaseRestorationdependleast27basepairsupstreamcodingDNAsequenceassociatedpresentsfutureovercomeIMPORTANCE:reportsfadDidentifyingvaluableprovidingbaselinemechanisticstudiescheckhighlevelInvestigatingMycobacteriumabscessusfattyacid-CoAligase

Similar Articles

Cited By

No available data.